Table of contents

Rheumatoid arthritis

• Original research: Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden (26 December, 2023)

  Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Benedicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
• Original research: Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study (20 December, 2023)

  Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
• Short report: Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis (19 December, 2023)

  Nathan J Dean, Ian J Clifton, Rashad Salman, Charles Bridgewood, Jacquie Nam, Tom Macleod, Dennis G McGonagle
• Original research: Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database (1 December, 2023)

  Pierre-Antoine Juge, Lidwine Wémeau-Stervinou, Sebastien Ottaviani, Guillaume Desjeux, Joe Zhuo, Virginie Vannier-Moreau, René-Marc Flipo, Bruno Crestani, Philippe Dieudé
• Original research: Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated (1 December, 2023)

  Reinder Raadsen, Romy Hansildaar, Lianne C Pouw, Femke Hooijberg, Laura Boekel, Gerrit Jan Wolbink, Arno W R van Kuijk, Michael T Nurmohamed
• Original research: Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association (1 December, 2023)

  Michelle D van den Beukel, Tineke J van Wesemael, Anna Titia W Hoogslag, Nicole V Borggreven, Tom WJ Huizinga, Annette HM van der Helm-van Mil, René EM Toes, Diane van der Woude, Leendert A Trouw
• Original research: Metabolomic profiles, polygenic risk scores and risk of rheumatoid arthritis: a population-based cohort study in the UK Biobank (30 November, 2023)

  Xin-Yu Fang, Jie Zhang, Ting-Ting Qian, Peng Gao, Qing Wu, Quan Fang, Su-Su Ke, Rong-Gui Huang, Heng-Chuan Zhang, Ni-Ni Qiao, Yin-Guang Fan, Dong-Qing Ye
• Original research: Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis (23 November, 2023)

  Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Benedicte Delcoigne, Johan Askling
• Original research: Time-varying risks of infection in patients as they proceed through the phases of ‘pre-RA’: results from the Scottish Early RA inception cohort (23 November, 2023)

  Duncan Porter, Sahil Jain, Evelyn Qian, Fraser R Morton, Iain B McInnes
• Original research: Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis (16 November, 2023)

  Joakim Lindqvist, Johan Askling, Jon Lampa
• Original research: Causal effects of time-varying body size on selected autoimmune disorders: a life course Mendelian randomisation study (14 November, 2023)

  Dennis Freuer, Christa Meisinger
• Original research: Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2–5 and MAXIMISE studies (9 November, 2023)

  Renaud Felten, Laura Widawski, Lionel Spielmann, Corine Gaillez, Weibin Bao, Jacques-Eric Gottenberg, Pierre-Marie Duret, Laurent Messer
• Original research: Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort (9 November, 2023)

  Daniel Montes, Cassondra A Hulshizer, Elena Myasoedova, John M Davis, Andrew C Hanson, Ali Duarte-Garcia, Gabriel Figueroa-Parra, Baptiste Chevet, Cynthia S Crowson
• Original research: Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System (31 October, 2023)

  Cécile Gaujoux-Viala, Jean-Francois Bergmann, Mélanie Goguillot, Asma Mélaine, Marie Guérin, Alban Edouard, Stève Bénard, Bruno Fautrel
• Original research: Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis (29 October, 2023)

  Haoming Yuan, Shaoxin Cui, Lin Yang, Jiehan Cui, Xiaoping Wang, Meng Ding, Lu Jin, Yanru Wang, Fei Chang, Hongtao Jin, Jun Ma, Min Shi, Aijing Liu
• Letter:

  Allele-specific protein binding within the CD40 locus in human synovial fibroblasts and immune cells

  (25 October, 2023)

  Larissa Moser, Katerina Laskari, Caroline Ospelt, Miranda Houtman
• Original research: Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register (25 October, 2023)

  Yvette Meissner, Martin Schäfer, Katinka Albrecht, Joern Kekow, Silke Zinke, Hans-Peter Tony, Anja Strangfeld
• Original research: Glucocorticoid trajectories over 2 years in patients with rheumatoid arthritis in a real-life setting (25 October, 2023)

  Alycia Delteil, Celine Lambert, Bruno Pereira, Marion Couderc, Sandrine Malochet-Guinamand, Marie Eva Pickering, Marc Villedon, Sylvain Mathieu, Martin Soubrier, Anne Tournadre
• Original research: Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab (6 October, 2023)

  Theresa Burkard, Enriqueta Vallejo-Yagüe, Kim Lauper, Axel Finckh, Thomas Hügle, Andrea M Burden